MedTrace Logo

Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes

NCT04776031 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2023-05-16

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and tolerability of the R:GEN Laser System in subjects with the early stages of age-related macular degeneration.

Conditions

  • Early Age Related Macular Degeneration (Disorder)

Interventions

DEVICE

R:GEN Laser System

Laser Treatment

Sponsors & Collaborators

  • Neuroscience Trials Australia

    collaborator OTHER

  • Lutronic Vision, Inc

    lead INDUSTRY

Principal Investigators

  • Robyn H Guymer, MBBS, PhD · Center for Eye Research Australia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2023-03-14
Completion
2023-03-14

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04776031 on ClinicalTrials.gov